x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
o | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Delaware | 46-4066644 | |||||||
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |
1400 American Lane Schaumburg, Illinois | 60173 | |||||||
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common Stock, par value $0.001 per share | PCTY | The NASDAQ Global Select Market LLC |
Large Accelerated Filer | x | Accelerated Filer | o | |||||||||||
Non-Accelerated Filer | o | Smaller Reporting Company | o | |||||||||||
Emerging Growth Company | o |
Page | |||||
June 30, 2021 | March 31, 2022 | ||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 202,287 | $ | 96,465 | |||||||
Corporate investments | 4,456 | — | |||||||||
Accounts receivable, net | 6,267 | 17,794 | |||||||||
Deferred contract costs | 44,230 | 54,735 | |||||||||
Prepaid expenses and other | 15,966 | 23,430 | |||||||||
Total current assets before funds held for clients | 273,206 | 192,424 | |||||||||
Funds held for clients | 1,759,677 | 4,324,567 | |||||||||
Total current assets | 2,032,883 | 4,516,991 | |||||||||
Capitalized internal-use software, net | 45,018 | 57,713 | |||||||||
Property and equipment, net | 59,835 | 64,004 | |||||||||
Operating lease right-of-use assets | 43,984 | 50,808 | |||||||||
Intangible assets, net | 13,027 | 48,245 | |||||||||
Goodwill | 33,650 | 102,183 | |||||||||
Long-term deferred contract costs | 170,663 | 209,580 | |||||||||
Long-term prepaid expenses and other | 4,223 | 7,910 | |||||||||
Deferred income tax assets | 11,602 | 21,804 | |||||||||
Total assets | $ | 2,414,885 | $ | 5,079,238 | |||||||
Liabilities and Stockholders’ Equity | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 4,230 | $ | 5,051 | |||||||
Accrued expenses | 103,109 | 108,820 | |||||||||
Total current liabilities before client fund obligations | 107,339 | 113,871 | |||||||||
Client fund obligations | 1,759,677 | 4,324,567 | |||||||||
Total current liabilities | 1,867,016 | 4,438,438 | |||||||||
Long-term operating lease liabilities | 67,201 | 71,178 | |||||||||
Other long-term liabilities | 1,958 | 2,422 | |||||||||
Deferred income tax liabilities | 1,780 | 1,781 | |||||||||
Total liabilities | $ | 1,937,955 | $ | 4,513,819 | |||||||
Stockholders’ equity: | |||||||||||
Preferred stock, $0.001 par value, 5,000 authorized, no shares issued and outstanding at June 30, 2021 and March 31, 2022 | $ | — | $ | — | |||||||
Common stock, $0.001 par value, 155,000 shares authorized at June 30, 2021 and March 31, 2022; 54,594 shares issued and outstanding at June 30, 2021 and 55,120 shares issued and outstanding at March 31, 2022 | 55 | 55 | |||||||||
Additional paid-in capital | 241,718 | 256,204 | |||||||||
Retained earnings | 235,091 | 310,722 | |||||||||
Accumulated other comprehensive income (loss) | 66 | (1,562) | |||||||||
Total stockholders' equity | $ | 476,930 | $ | 565,419 | |||||||
Total liabilities and stockholders’ equity | $ | 2,414,885 | $ | 5,079,238 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||||
Recurring and other revenue | $ | 184,927 | $ | 244,962 | $ | 465,195 | $ | 620,827 | |||||||||||||||
Interest income on funds held for clients | 1,126 | 1,008 | 2,981 | 2,877 | |||||||||||||||||||
Total revenues | 186,053 | 245,970 | 468,176 | 623,704 | |||||||||||||||||||
Cost of revenues | 57,326 | 75,538 | 160,248 | 209,608 | |||||||||||||||||||
Gross profit | 128,727 | 170,432 | 307,928 | 414,096 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Sales and marketing | 40,055 | 52,752 | 115,504 | 154,856 | |||||||||||||||||||
Research and development | 18,458 | 25,670 | 56,443 | 74,024 | |||||||||||||||||||
General and administrative | 31,071 | 44,632 | 87,038 | 119,448 | |||||||||||||||||||
Total operating expenses | 89,584 | 123,054 | 258,985 | 348,328 | |||||||||||||||||||
Operating income | 39,143 | 47,378 | 48,943 | 65,768 | |||||||||||||||||||
Other expense | (207) | (311) | (843) | (800) | |||||||||||||||||||
Income before income taxes | 38,936 | 47,067 | 48,100 | 64,968 | |||||||||||||||||||
Income tax expense (benefit) | 2,102 | 12,221 | (10,836) | (10,663) | |||||||||||||||||||
Net income | $ | 36,834 | $ | 34,846 | $ | 58,936 | $ | 75,631 | |||||||||||||||
Other comprehensive loss, net of tax | (126) | (1,218) | (536) | (1,628) | |||||||||||||||||||
Comprehensive income | $ | 36,708 | $ | 33,628 | $ | 58,400 | $ | 74,003 | |||||||||||||||
Net income per share: | |||||||||||||||||||||||
Basic | $ | 0.68 | $ | 0.63 | $ | 1.09 | $ | 1.38 | |||||||||||||||
Diluted | $ | 0.65 | $ | 0.62 | $ | 1.05 | $ | 1.34 | |||||||||||||||
Weighted-average shares used in computing net income per share: | |||||||||||||||||||||||
Basic | 54,415 | 55,114 | 54,244 | 54,996 | |||||||||||||||||||
Diluted | 56,414 | 56,367 | 56,338 | 56,437 |
Three Months Ended March 31, 2021 | |||||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||||||||
Balances at December 31, 2020 | 54,370 | $ | 54 | $ | 221,525 | $ | 186,374 | $ | 265 | $ | 408,218 | ||||||||||||||||||||||||
Stock-based compensation | — | — | 16,663 | — | — | 16,663 | |||||||||||||||||||||||||||||
Stock options exercised | 104 | — | 545 | — | — | 545 | |||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock units | 14 | — | — | — | — | — | |||||||||||||||||||||||||||||
Net settlement for taxes and/or exercise price related to equity awards | (37) | — | (7,525) | — | — | (7,525) | |||||||||||||||||||||||||||||
Unrealized losses on securities, net of tax | — | — | — | — | (126) | (126) | |||||||||||||||||||||||||||||
Net income | — | — | — | 36,834 | — | 36,834 | |||||||||||||||||||||||||||||
Balances at March 31, 2021 | 54,451 | $ | 54 | $ | 231,208 | $ | 223,208 | $ | 139 | $ | 454,609 |
Three Months Ended March 31, 2022 | |||||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||||||||
Balances at December 31, 2021 | 55,105 | $ | 55 | $ | 231,106 | $ | 275,876 | $ | (344) | $ | 506,693 | ||||||||||||||||||||||||
Stock-based compensation | — | — | 26,498 | — | — | 26,498 | |||||||||||||||||||||||||||||
Stock options exercised | 9 | — | 160 | — | — | 160 | |||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock units | 13 | — | — | — | — | — | |||||||||||||||||||||||||||||
Net settlement for taxes and/or exercise price related to equity awards | (7) | — | (1,560) | — | — | (1,560) | |||||||||||||||||||||||||||||
Unrealized losses on securities, net of tax | — | — | — | — | (1,218) | (1,218) | |||||||||||||||||||||||||||||
Net income | — | — | — | 34,846 | — | 34,846 | |||||||||||||||||||||||||||||
Balances at March 31, 2022 | 55,120 | $ | 55 | $ | 256,204 | $ | 310,722 | $ | (1,562) | $ | 565,419 |
Nine Months Ended March 31, 2021 | |||||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||||||||
Balances at June 30, 2020 | 53,792 | $ | 54 | $ | 227,907 | $ | 164,272 | $ | 675 | $ | 392,908 | ||||||||||||||||||||||||
Stock-based compensation | — | — | 48,896 | — | — | 48,896 | |||||||||||||||||||||||||||||
Stock options exercised | 338 | — | 2,477 | — | — | 2,477 | |||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock units | 622 | — | — | — | — | — | |||||||||||||||||||||||||||||
Issuance of common stock under employee stock purchase plan | 60 | — | 6,100 | — | — | 6,100 | |||||||||||||||||||||||||||||
Net settlement for taxes and/or exercise price related to equity awards | (361) | — | (54,172) | — | — | (54,172) | |||||||||||||||||||||||||||||
Unrealized losses on securities, net of tax | — | — | — | — | (536) | (536) | |||||||||||||||||||||||||||||
Net income | — | — | — | 58,936 | — | 58,936 | |||||||||||||||||||||||||||||
Balances at March 31, 2021 | 54,451 | $ | 54 | $ | 231,208 | $ | 223,208 | $ | 139 | $ | 454,609 |
Nine Months Ended March 31, 2022 | |||||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||||||||
Balances at June 30, 2021 | 54,594 | $ | 55 | $ | 241,718 | $ | 235,091 | $ | 66 | $ | 476,930 | ||||||||||||||||||||||||
Stock-based compensation | — | — | 75,726 | — | — | 75,726 | |||||||||||||||||||||||||||||
Stock options exercised | 204 | — | 1,972 | — | — | 1,972 | |||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock units | 549 | — | — | — | — | — | |||||||||||||||||||||||||||||
Issuance of common stock under employee stock purchase plan | 53 | — | 7,216 | — | — | 7,216 | |||||||||||||||||||||||||||||
Net settlement for taxes and/or exercise price related to equity awards | (280) | — | (70,428) | — | — | (70,428) | |||||||||||||||||||||||||||||
Unrealized losses on securities, net of tax | — | — | — | — | (1,628) | (1,628) | |||||||||||||||||||||||||||||
Net income | — | — | — | 75,631 | — | 75,631 | |||||||||||||||||||||||||||||
Balances at March 31, 2022 | 55,120 | $ | 55 | $ | 256,204 | $ | 310,722 | $ | (1,562) | $ | 565,419 |
Nine Months Ended March 31, | |||||||||||
2021 | 2022 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ | 58,936 | $ | 75,631 | |||||||
Adjustments to reconcile net income to net cash provided by operating activities | |||||||||||
Stock-based compensation expense | 46,947 | 70,197 | |||||||||
Depreciation and amortization expense | 32,070 | 36,419 | |||||||||
Deferred income tax benefit | (10,656) | (10,882) | |||||||||
Provision for credit losses | 213 | 238 | |||||||||
Net accretion of discounts and amortization of premiums on available-for-sale securities | 315 | 342 | |||||||||
Amortization of debt issuance costs | 127 | 136 | |||||||||
Other | 545 | 286 | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | (4,495) | (9,654) | |||||||||
Deferred contract costs | (39,621) | (49,205) | |||||||||
Prepaid expenses and other | (2,531) | (9,418) | |||||||||
Accounts payable | 1,592 | 141 | |||||||||
Accrued expenses and other | 2,318 | 1,163 | |||||||||
Net cash provided by operating activities | 85,760 | 105,394 | |||||||||
Cash flows from investing activities: | |||||||||||
Purchases of available-for-sale securities | — | (215,538) | |||||||||
Proceeds from sales and maturities of available-for-sale securities | 82,488 | 85,875 | |||||||||
Capitalized internal-use software costs | (21,664) | (26,285) | |||||||||
Purchases of property and equipment | (8,155) | (15,355) | |||||||||
Acquisitions of businesses, net of cash acquired | (14,992) | (107,576) | |||||||||
Other investing activities | — | (2,500) | |||||||||
Net cash provided by (used in) investing activities | 37,677 | (281,379) | |||||||||
Cash flows from financing activities: | |||||||||||
Net change in client fund obligations | 724,610 | 2,564,829 | |||||||||
Borrowings under credit facility | — | 50,000 | |||||||||
Repayment of credit facility | (100,000) | (50,000) | |||||||||
Proceeds from exercise of stock options | 146 | — | |||||||||
Proceeds from employee stock purchase plan | 6,100 | 7,216 | |||||||||
Taxes paid related to net share settlement of equity awards | (51,828) | (68,509) | |||||||||
Payment of debt issuance costs | (56) | (64) | |||||||||
Net cash provided by financing activities | 578,972 | 2,503,472 | |||||||||
Net change in cash, cash equivalents and funds held for clients' cash and cash equivalents | 702,409 | 2,327,487 | |||||||||
Cash, cash equivalents and funds held for clients' cash and cash equivalents—beginning of period | 1,492,133 | 1,945,881 | |||||||||
Cash, cash equivalents and funds held for clients' cash and cash equivalents—end of period | $ | 2,194,542 | $ | 4,273,368 | |||||||
Supplemental Disclosure of Non-Cash Investing and Financing Activities | |||||||||||
Purchases of property and equipment, accrued but not paid | $ | — | $ | 1,251 | |||||||
Liabilities assumed for acquisitions | $ | 281 | $ | 4,470 | |||||||
Supplemental Disclosure of Cash Flow Information | |||||||||||
Cash paid for interest | $ | 820 | $ | 257 | |||||||
Refunds received for income taxes | $ | (222) | $ | (115) | |||||||
Reconciliation of cash, cash equivalents and funds held for clients' cash and cash equivalents to the Consolidated Balance Sheets | |||||||||||
Cash and cash equivalents | $ | 175,453 | $ | 96,465 | |||||||
Funds held for clients' cash and cash equivalents | 2,019,089 | 4,176,903 | |||||||||
Total cash, cash equivalents and funds held for clients' cash and cash equivalents | $ | 2,194,542 | $ | 4,273,368 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
Recurring fees | $ | 178,711 | $ | 236,657 | $ | 448,864 | $ | 599,513 | |||||||||||||||
Implementation services and other | 6,216 | 8,305 | 16,331 | 21,314 | |||||||||||||||||||
Total revenues from contracts | $ | 184,927 | $ | 244,962 | $ | 465,195 | $ | 620,827 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
Balance at beginning of the period | $ | 7,065 | $ | 9,341 | $ | 8,434 | $ | 8,734 | |||||||||||||||
Deferral of revenue | 5,821 | 9,105 | 11,811 | 18,865 | |||||||||||||||||||
Revenue recognized | (4,097) | (6,044) | (11,456) | (15,197) | |||||||||||||||||||
Balance at end of the period | $ | 8,789 | $ | 12,402 | $ | 8,789 | $ | 12,402 |
Three Months Ended March 31, 2021 | |||||||||||||||||||||||
Beginning Balance | Capitalized Costs | Amortization | Ending Balance | ||||||||||||||||||||
Costs to obtain a new contract | $ | 125,817 | $ | 17,315 | $ | (7,390) | $ | 135,742 | |||||||||||||||
Costs to fulfill a contract | 55,657 | 8,872 | (2,607) | 61,922 | |||||||||||||||||||
Total | $ | 181,474 | $ | 26,187 | $ | (9,997) | $ | 197,664 |
Three Months Ended March 31, 2022 | |||||||||||||||||||||||
Beginning Balance | Capitalized Costs | Amortization | Ending Balance | ||||||||||||||||||||
Costs to obtain a new contract | $ | 155,564 | $ | 22,256 | $ | (9,182) | $ | 168,638 | |||||||||||||||
Costs to fulfill a contract | 86,115 | 13,825 | (4,263) | 95,677 | |||||||||||||||||||
Total | $ | 241,679 | $ | 36,081 | $ | (13,445) | $ | 264,315 |
Nine Months Ended March 31, 2021 | |||||||||||||||||||||||
Beginning Balance | Capitalized Costs | Amortization | Ending Balance | ||||||||||||||||||||
Costs to obtain a new contract | $ | 113,575 | $ | 43,026 | $ | (20,859) | $ | 135,742 | |||||||||||||||
Costs to fulfill a contract | 44,468 | 24,376 | (6,922) | 61,922 | |||||||||||||||||||
Total | $ | 158,043 | $ | 67,402 | $ | (27,781) | $ | 197,664 |
Nine Months Ended March 31, 2022 | |||||||||||||||||||||||
Beginning Balance | Capitalized Costs | Amortization | Ending Balance | ||||||||||||||||||||
Costs to obtain a new contract | $ | 145,718 | $ | 48,922 | $ | (26,002) | $ | 168,638 | |||||||||||||||
Costs to fulfill a contract | 69,175 | 37,865 | (11,363) | 95,677 | |||||||||||||||||||
Total | $ | 214,893 | $ | 86,787 | $ | (37,365) | $ | 264,315 |
August 31, 2021 | |||||
Proprietary technology | $ | 21,200 | |||
Client relationships | 3,000 | ||||
Trade names | 1,200 | ||||
Goodwill | 34,776 | ||||
Other assets acquired | 2,659 | ||||
Liabilities assumed | (1,874) | ||||
Total purchase price | $ | 60,961 |
January 18, 2022 | |||||
Proprietary technology | $ | 15,800 | |||
Goodwill | 33,757 | ||||
Other assets acquired | 3,041 | ||||
Liabilities assumed | (2,596) | ||||
Total purchase price | $ | 50,002 |
Balance at June 30, 2021 | $ | 800 | |||
Charged to expense | 238 | ||||
Write-offs | (183) | ||||
Balance at March 31, 2022 | $ | 855 |
June 30, 2021 | March 31, 2022 | ||||||||||
Capitalized internal-use software | $ | 150,922 | $ | 182,140 | |||||||
Accumulated amortization | (105,904) | (124,427) | |||||||||
Capitalized internal-use software, net | $ | 45,018 | $ | 57,713 |
June 30, 2021 | March 31, 2022 | ||||||||||
Office equipment | $ | 5,211 | $ | 4,365 | |||||||
Computer equipment | 45,420 | 54,172 | |||||||||
Furniture and fixtures | 13,104 | 12,791 | |||||||||
Software | 6,641 | 8,278 | |||||||||
Leasehold improvements | 46,814 | 47,255 | |||||||||
Time clocks rented by clients | 5,399 | 6,423 | |||||||||
Total | 122,589 | 133,284 | |||||||||
Accumulated depreciation | (62,754) | (69,280) | |||||||||
Property and equipment, net | $ | 59,835 | $ | 64,004 |
March 31, 2022 | |||||
Balance at June 30, 2021 | $ | 33,650 | |||
Additions attributable to acquisitions | 68,533 | ||||
Balance at March 31, 2022 | $ | 102,183 |
June 30, 2021 | March 31, 2022 | Weighted average useful life (years) | |||||||||||||||
Proprietary technology | $ | 6,129 | $ | 43,129 | 6.0 | ||||||||||||
Client relationships | 19,200 | 22,200 | 7.8 | ||||||||||||||
Non-solicitation agreements | 1,600 | 1,600 | 3.1 | ||||||||||||||
Trade names | 440 | 1,640 | 5.0 | ||||||||||||||
Total | 27,369 | 68,569 | |||||||||||||||
Accumulated amortization | (14,342) | (20,324) | |||||||||||||||
Intangible assets, net | $ | 13,027 | $ | 48,245 |
Remainder of fiscal 2022 | $ | 2,770 | |||
Fiscal 2023 | 10,948 | ||||
Fiscal 2024 | 9,943 | ||||
Fiscal 2025 | 8,888 | ||||
Fiscal 2026 | 7,269 | ||||
Thereafter | 8,427 | ||||
Total | $ | 48,245 |
June 30, 2021 | March 31, 2022 | ||||||||||
Accrued payroll and personnel costs | $ | 73,969 | $ | 67,965 | |||||||
Operating lease liabilities | 7,549 | 8,270 | |||||||||
Deferred revenue | 9,442 | 14,326 | |||||||||
Other | 12,149 | 18,259 | |||||||||
Total accrued expenses | $ | 103,109 | $ | 108,820 |
June 30, 2021 | ||||||||||||||||||||||||||
Type of Issue | Amortized cost | Gross unrealized gains | Gross unrealized losses | Fair value | ||||||||||||||||||||||
Cash and cash equivalents | $ | 202,287 | $ | — | $ | — | $ | 202,287 | ||||||||||||||||||
Funds held for clients' cash and cash equivalents | 1,743,594 | — | — | 1,743,594 | ||||||||||||||||||||||
Available-for-sale securities: | ||||||||||||||||||||||||||
Corporate bonds | 13,390 | 70 | — | 13,460 | ||||||||||||||||||||||
Asset-backed securities | 7,062 | 17 | — | 7,079 | ||||||||||||||||||||||
Total available-for-sale securities (1) | 20,452 | 87 | — | 20,539 | ||||||||||||||||||||||
Total investments | $ | 1,966,333 | $ | 87 | $ | — | $ | 1,966,420 |
(1) | Included within the fair value of total available-for-sale securities above is $4,456 of corporate investments and $16,083 of funds held for clients. |
March 31, 2022 | ||||||||||||||||||||||||||
Type of Issue | Amortized cost | Gross unrealized gains | Gross unrealized losses | Fair value | ||||||||||||||||||||||
Cash and cash equivalents | $ | 96,465 | $ | — | $ | — | $ | 96,465 | ||||||||||||||||||
Funds held for clients' cash and cash equivalents | 4,176,903 | — | — | 4,176,903 | ||||||||||||||||||||||
Available-for-sale securities: | ||||||||||||||||||||||||||
Commercial paper | 49,440 | — | (113) | 49,327 | ||||||||||||||||||||||
Corporate bonds | 54,607 | 1 | (1,289) | 53,319 | ||||||||||||||||||||||
Asset-backed securities | 8,082 | — | (135) | 7,947 | ||||||||||||||||||||||
Certificates of deposit | 23,785 | — | (50) | 23,735 | ||||||||||||||||||||||
U.S treasury securities | 4,036 | — | (90) | 3,946 | ||||||||||||||||||||||
U.S government agency securities | 7,000 | — | (372) | 6,628 | ||||||||||||||||||||||
Other | 2,823 | — | (61) | 2,762 | ||||||||||||||||||||||
Total available-for-sale securities (2) | 149,773 | 1 | (2,110) | 147,664 | ||||||||||||||||||||||
Total investments | $ | 4,423,141 | $ | 1 | $ | (2,110) | $ | 4,421,032 |
(2) | All available-for-sale securities are included in funds held for clients. |
June 30, 2021 | March 31, 2022 | ||||||||||
Cash and cash equivalents | $ | 202,287 | $ | 96,465 | |||||||
Corporate investments | 4,456 | — | |||||||||
Funds held for clients | 1,759,677 | 4,324,567 | |||||||||
Total investments | $ | 1,966,420 | $ | 4,421,032 |
March 31, 2022 | |||||||||||
Securities in an unrealized loss position for less than 12 months | |||||||||||
Gross unrealized losses | Fair Value | ||||||||||
Commercial paper | $ | (113) | $ | 49,327 | |||||||
Corporate bonds | (1,289) | 51,909 | |||||||||
Asset-backed securities | (135) | 7,826 | |||||||||
Certificates of deposit | (50) | 22,734 | |||||||||
U.S. treasury securities | (90) | 3,946 | |||||||||
U.S. government agency securities | (372) | 6,628 | |||||||||
Other | (61) | 2,762 | |||||||||
Total available-for-sale securities | $ | (2,110) | $ | 145,132 |
Amortized cost | Fair value | ||||||||||
One year or less | $ | 98,775 | $ | 98,392 | |||||||
One year to two years | 26,988 | 26,369 | |||||||||
Two years to three years | 20,000 | 19,138 | |||||||||
Three years to five years | 4,010 | 3,765 | |||||||||
Total available-for-sale securities | $ | 149,773 | $ | 147,664 |
June 30, 2021 | |||||||||||||||||||||||
Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
Cash and cash equivalents | $ | 202,287 | $ | 202,287 | $ | — | $ | — | |||||||||||||||
Funds held for clients' cash and cash equivalents | 1,743,594 | 1,743,594 | — | — | |||||||||||||||||||
Available-for-sale securities: | |||||||||||||||||||||||
Corporate bonds | 13,460 | — | 13,460 | — | |||||||||||||||||||
Asset-backed securities | 7,079 | — | 7,079 | — | |||||||||||||||||||
Total available-for-sale securities | 20,539 | — | 20,539 | — | |||||||||||||||||||
Total investments | $ | 1,966,420 | $ | 1,945,881 | $ | 20,539 | $ | — |
March 31, 2022 | |||||||||||||||||||||||
Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
Cash and cash equivalents | $ | 96,465 | $ | 96,465 | $ | — | $ | — | |||||||||||||||
Funds held for clients' cash and cash equivalents | 4,176,903 | 4,176,903 | — | — | |||||||||||||||||||
Available-for-sale securities: | |||||||||||||||||||||||
Commercial paper | 49,327 | — | 49,327 | — | |||||||||||||||||||
Corporate bonds | 53,319 | — | 53,319 | — | |||||||||||||||||||
Asset-backed securities | 7,947 | — | 7,947 | — | |||||||||||||||||||
Certificates of deposit | 23,735 | — | 23,735 | — | |||||||||||||||||||
U.S. treasury securities | 3,946 | — | 3,946 | — | |||||||||||||||||||
U.S government agency securities | 6,628 | — | 6,628 | — | |||||||||||||||||||
Other | 2,762 | — | 2,762 | — | |||||||||||||||||||
Total available-for-sale securities | 147,664 | — | 147,664 | — | |||||||||||||||||||
Total investments | $ | 4,421,032 | $ | 4,273,368 | $ | 147,664 | $ | — |
Number of Shares | |||||
Available for grant at July 1, 2021 | 10,312 | ||||
January 1, 2022 Evergreen provision increase | 2,400 | ||||
RSUs granted | (614) | ||||
MSUs granted | (47) | ||||
Shares withheld in settlement of taxes and/or exercise price | 280 | ||||
Forfeitures | 120 | ||||
Shares removed | (59) | ||||
Available for grant at March 31, 2022 | 12,392 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
Cost of revenues | $ | 1,972 | $ | 2,936 | $ | 5,773 | $ | 8,860 | |||||||||||||||
Sales and marketing | 3,938 | 5,119 | 11,783 | 15,994 | |||||||||||||||||||
Research and development | 2,602 | 4,855 | 7,570 | 13,963 | |||||||||||||||||||
General and administrative | 7,499 | 11,485 | 21,821 | 31,380 | |||||||||||||||||||
Total stock-based compensation expense | $ | 16,011 | $ | 24,395 | $ | 46,947 | $ | 70,197 |
Outstanding Options | |||||||||||||||||||||||
Number of shares | Weighted average exercise price | Weighted average remaining contractual term (years) | Aggregate intrinsic value | ||||||||||||||||||||
Balance at July 1, 2021 | 765 | $ | 16.06 | 2.4 | $ | 133,550 | |||||||||||||||||
Options exercised | (204) | $ | 9.69 | ||||||||||||||||||||
Balance at March 31, 2022 | 561 | $ | 18.37 | 1.8 | $ | 105,094 | |||||||||||||||||
Options vested and exercisable at March 31, 2022 | 561 | $ | 18.37 | 1.8 | $ | 105,094 |
Units | Weighted average grant date fair value | ||||||||||
RSU balance at July 1, 2021 | 1,388 | $ | 100.33 | ||||||||
RSUs granted | 614 | $ | 247.98 | ||||||||
RSUs vested | (549) | $ | 84.83 | ||||||||
RSUs forfeited | (115) | $ | 160.61 | ||||||||
RSU balance at March 31, 2022 | 1,338 | $ | 169.40 |
Units | Weighted average grant date fair value | ||||||||||
MSU balance at July 1, 2021 | 58 | $ | 178.04 | ||||||||
MSUs granted | 48 | $ | 361.02 | ||||||||
MSUs forfeited | (5) | $ | 178.04 | ||||||||
MSU balance at March 31, 2022 | 101 | $ | 263.83 |
Nine Months Ended March 31, | ||||||||||||||
2021 | 2022 | |||||||||||||
Valuation assumptions: | ||||||||||||||
Expected dividend yield | —% | —% | ||||||||||||
Expected volatility | 52.0 | % | 47.4 - 47.5% | |||||||||||
Expected term (years) | 3.04 | 2.92 - 3.04 | ||||||||||||
Risk‑free interest rate | 0.18% | 0.43 - 0.47% |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Net income | $ | 36,834 | $ | 34,846 | $ | 58,936 | $ | 75,631 | |||||||||||||||
Denominator: | |||||||||||||||||||||||
Weighted-average shares used in computing net income per share: | |||||||||||||||||||||||
Basic | 54,415 | 55,114 | 54,244 | 54,996 | |||||||||||||||||||
Weighted-average effect of potentially dilutive shares: | |||||||||||||||||||||||
Employee stock options, restricted stock units, market share units and employee stock purchase plan shares | 1,999 | 1,253 | 2,094 | 1,441 | |||||||||||||||||||
Diluted | 56,414 | 56,367 | 56,338 | 56,437 | |||||||||||||||||||
Net income per share: | |||||||||||||||||||||||
Basic | $ | 0.68 | $ | 0.63 | $ | 1.09 | $ | 1.38 | |||||||||||||||
Diluted | $ | 0.65 | $ | 0.62 | $ | 1.05 | $ | 1.34 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
Market share units | — | 19 | — | 19 | |||||||||||||||||||
Restricted stock units | 1 | 62 | 13 | 59 | |||||||||||||||||||
Total | 1 | 81 | 13 | 78 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
(in thousands) | (in thousands) | ||||||||||||||||||||||
Adjusted Gross Profit | $ | 136,728 | $ | 179,764 | $ | 331,602 | $ | 442,545 | |||||||||||||||
Adjusted EBITDA | 66,941 | 85,717 | 132,775 | 178,456 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
(in thousands) | (in thousands) | ||||||||||||||||||||||
Reconciliation from Gross Profit to Adjusted Gross Profit | |||||||||||||||||||||||
Gross profit | $ | 128,727 | $ | 170,432 | $ | 307,928 | $ | 414,096 | |||||||||||||||
Amortization of capitalized internal-use software costs | 6,005 | 6,308 | 17,273 | 18,523 | |||||||||||||||||||
Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises | 1,996 | 2,978 | 6,401 | 9,832 | |||||||||||||||||||
Other items (1) | — | 46 | — | 94 | |||||||||||||||||||
Adjusted Gross Profit | $ | 136,728 | $ | 179,764 | $ | 331,602 | $ | 442,545 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
(in thousands) | (in thousands) | ||||||||||||||||||||||
Reconciliation from Net income to Adjusted EBITDA | |||||||||||||||||||||||
Net income | $ | 36,834 | $ | 34,846 | $ | 58,936 | $ | 75,631 | |||||||||||||||
Interest expense | 204 | 168 | 895 | 386 | |||||||||||||||||||
Income tax expense (benefit) | 2,102 | 12,221 | (10,836) | (10,663) | |||||||||||||||||||
Depreciation and amortization expense | 10,999 | 13,036 | 32,070 | 36,419 | |||||||||||||||||||
EBITDA | 50,139 | 60,271 | 81,065 | 101,773 | |||||||||||||||||||
Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises | 16,510 | 24,640 | 50,333 | 74,866 | |||||||||||||||||||
Other items (2) | 292 | 806 | 1,377 | 1,817 | |||||||||||||||||||
Adjusted EBITDA | $ | 66,941 | $ | 85,717 | $ | 132,775 | $ | 178,456 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
(in thousands) | (in thousands) | ||||||||||||||||||||||
Capitalized portion of research and development | $ | 8,086 | $ | 10,914 | $ | 23,476 | $ | 31,218 | |||||||||||||||
Expensed portion of research and development | 18,458 | 25,670 | 56,443 | 74,024 | |||||||||||||||||||
Total research and development | $ | 26,544 | $ | 36,584 | $ | 79,919 | $ | 105,242 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
(in thousands) | (in thousands) | ||||||||||||||||||||||
Consolidated Statements of Operations Data: | |||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||
Recurring and other revenue | $ | 184,927 | $ | 244,962 | $ | 465,195 | $ | 620,827 | |||||||||||||||
Interest income on funds held for clients | 1,126 | 1,008 | 2,981 | 2,877 | |||||||||||||||||||
Total revenues | 186,053 | 245,970 | 468,176 | 623,704 | |||||||||||||||||||
Cost of revenues | 57,326 | 75,538 | 160,248 | 209,608 | |||||||||||||||||||
Gross profit | 128,727 | 170,432 | 307,928 | 414,096 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Sales and marketing | 40,055 | 52,752 | 115,504 | 154,856 | |||||||||||||||||||
Research and development | 18,458 | 25,670 | 56,443 | 74,024 | |||||||||||||||||||
General and administrative | 31,071 | 44,632 | 87,038 | 119,448 | |||||||||||||||||||
Total operating expenses | 89,584 | 123,054 | 258,985 | 348,328 | |||||||||||||||||||
Operating income | 39,143 | 47,378 | 48,943 | 65,768 | |||||||||||||||||||
Other expense | (207) | (311) | (843) | (800) | |||||||||||||||||||
Income before income taxes | 38,936 | 47,067 | 48,100 | 64,968 | |||||||||||||||||||
Income tax expense (benefit) | 2,102 | 12,221 | (10,836) | (10,663) | |||||||||||||||||||
Net income | $ | 36,834 | $ | 34,846 | $ | 58,936 | $ | 75,631 |
Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
2021 | 2022 | 2021 | 2022 | ||||||||||||||||||||
Consolidated Statements of Operations Data: | |||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||
Recurring and other revenue | 99 | % | 100 | % | 99 | % | 100 | % | |||||||||||||||
Interest income on funds held for clients | 1 | % | 0 | % | 1 | % | 0 | % | |||||||||||||||
Total revenues | 100 | % | 100 | % | 100 | % | 100 | % | |||||||||||||||
Cost of revenues | 31 | % | 31 | % | 34 | % | 34 | % | |||||||||||||||
Gross profit | 69 | % | 69 | % | 66 | % | 66 | % | |||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Sales and marketing | 21 | % | 21 | % | 25 | % | 25 | % | |||||||||||||||
Research and development | 10 | % | 11 | % | 12 | % | 12 | % | |||||||||||||||
General and administrative | 17 | % | 18 | % | 18 | % | 19 | % | |||||||||||||||
Total operating expenses | 48 | % | 50 | % | 55 | % | 56 | % | |||||||||||||||
Operating income | 21 | % | 19 | % | 11 | % | 10 | % | |||||||||||||||
Other expense | 0 | % | 0 | % | 0 | % | 0 | % | |||||||||||||||
Income before income taxes | 21 | % | 19 | % | 11 | % | 10 | % | |||||||||||||||
Income tax expense (benefit) | 1 | % | 5 | % | (2) | % | (2) | % | |||||||||||||||
Net income | 20 | % | 14 | % | 13 | % | 12 | % |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
Recurring and other revenue | $ | 184,927 | $ | 244,962 | $ | 60,035 | 32 | % | |||||||||||||||
Percentage of total revenues | 99 | % | 100 | % | |||||||||||||||||||
Interest income on funds held for clients | $ | 1,126 | $ | 1,008 | $ | (118) | (10) | % | |||||||||||||||
Percentage of total revenues | 1 | % | 0 | % |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
Cost of revenues | $ | 57,326 | $ | 75,538 | $ | 18,212 | 32 | % | |||||||||||||||
Percentage of total revenues | 31% | 31 | % | ||||||||||||||||||||
Gross margin | 69% | 69 | % |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
Sales and marketing | $ | 40,055 | $ | 52,752 | $ | 12,697 | 32 | % | |||||||||||||||
Percentage of total revenues | 21 | % | 21 | % |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
Research and development | $ | 18,458 | $ | 25,670 | $ | 7,212 | 39 | % | |||||||||||||||
Percentage of total revenues | 10 | % | 11 | % |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
General and administrative | $ | 31,071 | $ | 44,632 | $ | 13,561 | 44 | % | |||||||||||||||
Percentage of total revenues | 17 | % | 18 | % |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
Other expense | (207) | (311) | $ | (104) | 50 | % | |||||||||||||||||
Percentage of total revenues | 0 | % | 0 | % |
Nine Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
Recurring and other revenue | $ | 465,195 | $ | 620,827 | $ | 155,632 | 33 | % | |||||||||||||||
Percentage of total revenues | 99 | % | 100 | % | |||||||||||||||||||
Interest income on funds held for clients | $ | 2,981 | $ | 2,877 | $ | (104) | (3) | % | |||||||||||||||
Percentage of total revenues | 1 | % | 0 | % |
Nine Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
Cost of revenues | $ | 160,248 | $ | 209,608 | $ | 49,360 | 31 | % | |||||||||||||||
Percentage of total revenues | 34% | 34 | % | ||||||||||||||||||||
Gross margin | 66% | 66 | % |
Nine Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
Sales and marketing | $ | 115,504 | $ | 154,856 | $ | 39,352 | 34 | % | |||||||||||||||
Percentage of total revenues | 25 | % | 25 | % |
Nine Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
Research and development | $ | 56,443 | $ | 74,024 | $ | 17,581 | 31 | % | |||||||||||||||
Percentage of total revenues | 12 | % | 12 | % |
Nine Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
General and administrative | $ | 87,038 | $ | 119,448 | $ | 32,410 | 37 | % | |||||||||||||||
Percentage of total revenues | 18 | % | 19 | % |
Nine Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2022 | $ | % | ||||||||||||||||||||
Other expense | (843) | (800) | $ | 43 | (5) | % | |||||||||||||||||
Percentage of total revenues | 0 | % | 0 | % |
Nine Months Ended March 31, | |||||||||||
2021 | 2022 | ||||||||||
Net cash provided by operating activities | $ | 85,760 | $ | 105,394 | |||||||
Cash flows from investing activities: | |||||||||||
Purchases of available-for-sale securities | — | (215,538) | |||||||||
Proceeds from sales and maturities of available-for-sale securities | 82,488 | 85,875 | |||||||||
Capitalized internal-use software costs | (21,664) | (26,285) | |||||||||
Purchases of property and equipment | (8,155) | (15,355) | |||||||||
Acquisitions of businesses, net of cash acquired | (14,992) | (107,576) | |||||||||
Other investing activities | — | (2,500) | |||||||||
Net cash provided by (used in) investing activities | 37,677 | (281,379) | |||||||||
Cash flows from financing activities: | |||||||||||
Net change in client fund obligations | 724,610 | 2,564,829 | |||||||||
Borrowings under credit facility | — | 50,000 | |||||||||
Repayment of credit facility | (100,000) | (50,000) | |||||||||
Proceeds from exercise of stock options | 146 | — | |||||||||
Proceeds from employee stock purchase plan | 6,100 | 7,216 | |||||||||
Taxes paid related to net share settlement of equity awards | (51,828) | (68,509) | |||||||||
Payment of debt issuance costs | (56) | (64) | |||||||||
Net cash provided by financing activities | 578,972 | 2,503,472 | |||||||||
Net change in cash, cash equivalents and funds held for clients' cash and cash equivalents | 702,409 | 2,327,487 |
Payment Due By Fiscal Period | |||||||||||||||||||||||||||||
Total | Less than 1 Year | 1-3 Years | 3-5 Years | More than 5 Years | |||||||||||||||||||||||||
Operating lease obligations | $ | 93,468 | $ | 10,760 | $ | 19,847 | $ | 19,014 | $ | 43,847 | |||||||||||||||||||
Purchase obligations | 28,139 | 15,967 | 8,664 | 3,508 | — | ||||||||||||||||||||||||
$ | 121,607 | $ | 26,727 | $ | 28,511 | $ | 22,522 | $ | 43,847 |
Exhibit Nos. | Description | |||||||
101.INS* | XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). | |||||||
101.SCH* | XBRL Taxonomy Extension Schema Document. | |||||||
101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document. | |||||||
101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document. | |||||||
101.LAB* | XBRL Taxonomy Extension Label Linkbase Document. | |||||||
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document. | |||||||
104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
PAYLOCITY HOLDING CORPORATION | |||||||||||
Date: | May 6, 2022 | By: | /s/ Steven R. Beauchamp | ||||||||
Name: | Steven R. Beauchamp | ||||||||||
Title: | Co-Chief Executive Officer (Principal Executive Officer) and Director | ||||||||||
Date: | May 6, 2022 | By: | /s/ Toby J. Williams | ||||||||
Name: | Toby J. Williams | ||||||||||
Title: | President, Co-Chief Executive Officer (Principal Executive Officer) and Director | ||||||||||
Date: | May 6, 2022 | By: | /s/ Ryan Glenn | ||||||||
Name: | Ryan Glenn | ||||||||||
Title: | Chief Financial Officer and Treasurer (Principal Financial Officer) |
Participant: | Employee ID: | ||||||||||
Date of Grant: | |||||||||||
Total Number of Units: | , subject to adjustment as provided by the Restricted Stock Units Agreement. | ||||||||||
Settlement Date: | Except as provided by the Restricted Stock Units Agreement, the date on which a Unit becomes a Vested Unit. | ||||||||||
Vesting Start Date: | |||||||||||
Vested Units: | Except as provided in the Restricted Stock Units Agreement and provided that the Participant’s Service has not terminated prior to the applicable date, the number of Vested Units (disregarding any resulting fractional Unit) as of any date is determined by multiplying the Total Number of Units by the “Vested Ratio” determined as of such date, as follows: | ||||||||||
Vested Ratio | |||||||||||
...……………………………………………... | |||||||||||
Superseding Agreement: | None |
PAYLOCITY HOLDING CORPORATION | PARTICIPANT | |||||||
By: Steven Beauchamp Paylocity Corporation Co-Chief Executive Officer | ||||||||
Signature | ||||||||
Date | ||||||||
Address: 1400 American Lane Schaumburg, IL 60173 | ||||||||
Address | ||||||||
Date: May 6, 2022 | /s/ Steven R. Beauchamp | |||||||
Name: | Steven R. Beauchamp | |||||||
Title: | Co-Chief Executive Officer (Principal Executive Officer) and Director |
Date: May 6, 2022 | /s/ Toby J. Williams | |||||||
Name: | Toby J. Williams | |||||||
Title: | President, Co-Chief Executive Officer (Principal Executive Officer) and Director |
Date: May 6, 2022 | /s/ Ryan Glenn | |||||||
Name: | Ryan Glenn | |||||||
Title: | Chief Financial Officer and Treasurer (Principal Financial Officer) |
Date: May 6, 2022 | /s/ Steven R. Beauchamp | |||||||
Name: | Steven R. Beauchamp | |||||||
Title: | Co-Chief Executive Officer (Principal Executive Officer) and Director |
Date: May 6, 2022 | /s/ Toby J. Williams | |||||||
Name: | Toby J. Williams | |||||||
Title: | President, Co-Chief Executive Officer (Principal Executive Officer) and Director |
Date: May 6, 2022 | /s/ Ryan Glenn | |||||||
Name: | Ryan Glenn | |||||||
Title: | Chief Financial Officer and Treasurer (Principal Financial Officer) |